PROXY PHARMA
ActiveSummary
PROXY PHARMA has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €21,794 and a net result of €52,432. Equity is shrinking by ~13.2% per year across the filed fiscal years. Its solvency ranks better than 15% of 12386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Register details
Identification
Legal formPrivate limited company
Founded07-04-2017
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0673992721
Also
9925:BE0673992721
Registered
02-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 5 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Beauvechain · 1 establishment unit since 2017
Ground area
2,631 m²
Building footprint
1,590 m²
Volume, LiDAR
13,987 m³
2 parcels, Brussels, Wallonia · tallest building 20.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
PROXY PHARMA
since 2017unit no. 2.264.578.826
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21572B0086/00V000 | Brussels | 1,444 m² | 1 · 1,440 m² | 20.8 m · 2 fl. |
| 25103E0629/00L000 | Wallonia | 1,188 m² | 1 · 150 m² | 8.4 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.